Aging Population Drives Growth in the Intravenous Solutions (Parenteral Nutrition) Market, According to a New Report by Global Industry Analysts, Inc.
San Jose, CA (PRWEB) July 17, 2013
Follow us on LinkedIn The high prevalence of malnutrition during hospitalization is a growing concern for the healthcare sector, given that low nutritional levels increase hospital stay and the risk of patient mortality. Non-volitional nutrition support therapy, primarily in the form of Parenteral Nutrition and Enteral Nutrition, are traditionally administered to critically-ill surgical and medical patients who are unable to ingest food orally. The medical community is exploring the possibilities of a holistic combination of parenteral nutrition and enteral nutrition as a proactive treatment strategy for improving nutritional delivery. As a result, Parenteral Nutrition Therapy, one of the main modalities of clinical nutrition, represents one of the fastest growing markets in the global pharmaceutical industry.
Malnutrition is among the most common diagnoses among cancer patients, with weight loss and anorexia among the chief concerns of advanced-stage patients, families, and care providers. Intravenous solutions form an integral part of clinical care related to chronic health conditions. Intravenous vitamin C has proven to be effective in destroying cancer cells and the therapy is being widely adopted for the treatment of various types of cancers. Intravenous vitamin C significantly improved the quality of life of patients, especially breast cancer patients. Total Parenteral Nutrition is also found to positively influence overall survival rate, disease-free survival rate and relapse time in patients undergoing bone marrow therapy. Similarly, worldwide, the incidence and prevalence of Type II diabetes is increasing, and the number of diabetic individuals reached an estimated 371 million in 2012. Parenteral nutrition therapy offers several benefits to diabetes mellitus patients including enhanced immune function and fluid maintenance.
Growing aging population base represents a major growth driver in the Intravenous Solutions market. The impact of the burgeoning aging populace on disease statistics is underscored by the fact that over a quarter of the elderly population in the United States, and about a fifth of Europes old adult populace is suffering from diabetes. Emerging markets, such as China and India, are not insulated from this trend, as the large elderly demography in these populous countries is also contributing to this trend. Increase in the number of cardiovascular and renal diseases with age augurs well for the intravenous solutions market.
The increasing adoption of intravenous solutions on an outpatient basis driven by the growing consumer preference for complementary and surrogate environment for faster recuperation and convalescence is anticipated to propel the global intravenous solutions market in the near future. These underlying trends also promise a bright future for the use of intravenous solutions for parenteral nutrition therapy in home care setting. Use of Peripheral Intravenous Nutrition (PIN) has been growing at a rapid pace, especially in Europe and the United States. Out-patient PIN is also often associated with advantages, such as short infusion duration, high osmolality and high infusion rates.
Europe and the United States dominate the global market, as stated by the new market research report on Intravenous Solutions (Parenteral Nutrition). Asia-Pacific region is forecast to emerge as the fastest growing regional market with a CAGR of 13% over the analysis period. Despite the fact that parenteral nutrition offers several advantages such as quicker therapy duration, a large portion of the population still opt for therapy through the enteral route. This strong preference for enteral nutrition therapy in the region is primarily due to the cheaper costs, lower risk, and convenience offered by the modality. Moreover, in case of intravenous therapy, medication errors in terms of dosage administered occur in over a fourth of the patients. Manufacturers are therefore attempting to reduce risks and costs of errors by designing and engineering equipment with cutting edge safety features.
Key players in the market include Baxter International Inc., Fresenius Kabi, B. Braun Melsungen AG, Hospira Inc., Actavis Inc., Claris Lifesciences Ltd., Otsuka Pharmaceutical Factory Inc., Marck Biosciences Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Sino-Swed Pharmaceutical Corp., Ltd., Terumo Corp., and The Galenica Group.
The research report titled Intravenous Solutions (Parenteral Nutrition): A Global Strategic Business Report announced by Global Industry Analysts Inc., provides a comprehensive review of the parenteral nutrition industry, shedding light on the current and future trends influencing the market peppered with pertinent statistics, as well as major growth drivers and challenges. The research report also showcases the competitive landscape and recent activity. Revenue sales estimates and forecasts expressed in US$ are segmented into major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, Australia and Rest of Asia-Pacific), Latin America, and Rest of World.
For more details about this comprehensive market research report, please visit
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world’s largest and reputed market research firms.
Follow us on LinkedIn
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/